期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | MOLECULAR AND CELLULAR ENDOCRINOLOGY LetPub Score 7.8
50 ratings
Rate
Reputation 8.8 Influence 6.5 Speed 9.3 | ||||||||||||||||||||||||
期刊簡稱 | MOL CELL ENDOCRINOL | ||||||||||||||||||||||||
ISSN | 0303-7207 | ||||||||||||||||||||||||
E-ISSN | 1872-8057 | ||||||||||||||||||||||||
h-index | 131 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 2.60%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.journals.elsevier.com/molecular-and-cellular-endocrinology | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/MCE | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Elsevier Ireland Ltd | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | NETHERLANDS | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 1974 | ||||||||||||||||||||||||
每年文章數 | 142每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 25.68% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0303-7207%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2.2 Month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 38.75% | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[MOLECULAR AND CELLULAR ENDOCRINOLOGY] 的評論 | 撰寫評論 |
作者: 嘻嘻999 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-29 15:20:34 評論於 The submission interface displays "under review" but does not provide an online link. Does this mean it is still under editing and review?(0) 讚! | 嘻嘻999 |
作者: 嘻嘻999 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-29 15:19:19 評論於 Will the editing review show "under review"?(0) 讚! | 嘻嘻999 |
作者: Norman Aldington 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-14 09:09:17 評論於 Review speed: 1.0 | Submission acceptance rate: 50.0 Research focus: Reproductive endocrinology Experience sharing: The editor tends to give conditional rejections, but revisions are often possible(0) 讚! | Norman Aldington |
作者: 仲夏思彤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-09 10:40:55 評論於 Can this magazine only have one corresponding author?(0) 讚! | 仲夏思彤 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:19:11 評論於 Yes(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:22:21 評論於 The corresponding author of a SCI journal article does not necessarily have to be only one person, there is no fixed standard for how many. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only recognize one corresponding author, if a paper has multiple corresponding authors, the first corresponding author will be automatically selected as the corresponding author. For SCI journals that recognize two corresponding authors, two corresponding authors can be listed. The same applies to other requirements. In other words, the number of corresponding authors listed by the authors must comply with the regulations of the target SCI journal. The first author of a SCI paper is the person who has made the greatest contribution to the experiment and writing of the paper, and is the person listed first in the author section. However, in cases of multiple contributors, it is common to have co-first authors. As for the number of co-first authors, there is no specific regulation, and it depends largely on the workload of the paper, its length, the regulations of the publishing journal, and the recognition of the institution. Generally speaking, having 2-4 first authors in a SCI paper is most common(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 18:48:35 評論於 How many corresponding authors/first authors can a journal have?(0) 讚! | 北国博达 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 15:46:29 評論於 Do all authors receive an email after their article is accepted?(0) 讚! | 破戒阳平 |
作者: 桃花毅蒙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-10-20 16:50:13 評論於 A very professional magazine that requires in-depth research(0) 讚! | 桃花毅蒙 |
作者: Oliver Jerry 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-25 19:22:19 評論於 Keep up the good work(0) 讚! | Oliver Jerry |
作者: 五轮博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-13 17:29:11 評論於 The review seems professional, but I guess the content doesn't match, so it was rejected(0) 讚! | 五轮博达 |
作者: 北风依珊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-08-19 15:42:21 評論於 Are articles submitted for review immediately after your submission? ^_^(0) 讚! | 北风依珊 |
作者: 雨巷少年竹筱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-11 10:27:42 評論於 The first-instance opinion on September 30, 2018, was returned on November 4, 2018, and the status was revised. The decision was conditionally rejected, with two months given to supplement some small experiments. The revised version was accepted on January 10, 2019(0) 讚! | 雨巷少年竹筱 |
作者: 坂田之容 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-05 20:37:50 評論於 I just received a new article recently and had to revise dozens of issues. This journal has high requirements for articles, focusing on fundamentals and innovation. I hope to continue to work hard(0) 讚! | 坂田之容 |
作者: 暴风青丝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-09-26 15:12:47 評論於 What should I do in this situation? Can I resubmit?(0) 讚! | 暴风青丝 |
作者: 康平酱大魔王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-08-06 09:48:55 評論於 Review speed: 1.0 | Submission acceptance rate: 50.0 Experience sharing: Submitted on June 24th, received a response on July 10th. Both reviewers suggested major revisions, but the editor rejected the submission(0) 讚! | 康平酱大魔王 |
作者: 康平酱大魔王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-06-03 18:18:24 評論於 It's been over a month since I applied, and I still haven't received any feedback(0) 讚! | 康平酱大魔王 |
作者: 西风子爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-06-01 18:33:22 評論於 Review speed: 1.0 | Submission acceptance rate: 50.0 Experience sharing: 1.29 for submissions, 2.23 for minor revisions, 3.21 for acceptances in a journal with high acceptance efficiency(0) 讚! | 西风子爱 |
作者: 努力啊大语诗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-12-23 12:08:38 評論於 The magazine editor processes articles quickly, the reviewer's comments are also fair, there are no page fees, color images in printed versions incur a charge, while online color images are free. If you don't buy the printed version, you won't need to spend extra money(0) 讚! | 努力啊大语诗 |
作者: 努力啊大骊萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-10-08 13:40:48 評論於 Hello, is the layout fee of this magazine expensive? Thank you Monet 2016-06-07 Posted:: Acceptance rate: about 50% Review time: about 1 month I feel that this magazine is very efficient. Five days after submitting the manuscript, it entered external review. The review took three weeks, with two reviewers each providing 6 comments, requesting two small experiments and language polishing. The editor gave a conditional rejection, meaning revisions were needed. It took a month to do the experiments and polish the language. The manuscript was sent back to the reviewers the next day, and feedback was received in ten days. One reviewer had no comments, while the other requested to add a low-power image of the pathological section. The editor gave another conditional rejection, but kindly explained in the letter that adding the image would lead to acceptance. So the image was added and resubmitted on the same day, and on the third day, it was accepted. Overall, it took a little over two months, but the magazine's efficiency is commendable. I hope this information is helpful for everyone(0) 讚! | 努力啊大骊萍 |
作者: 岭南晨涛 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-07-08 23:40:30 評論於 How much is the layout fee for this magazine? Can anyone who has submitted before tell me?(0) 讚! | 岭南晨涛 |
作者: 云来甲戌 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-06-07 19:06:39 評論於 Review speed: 1.0 | Submission hit rate: 50.0 Experience sharing: I feel that this journal has a very high efficiency. After submitting the article, it entered external review five days later. The review process took three weeks, during which two reviewers each provided 6 comments, requesting additional experiments and language editing. The editor gave a conditional rejection, meaning revisions were required. It took a month to complete the additional experiments and editing. The article was resubmitted to the reviewers the next day, and feedback was received in ten days. One reviewer had no further comments, while the other requested the addition of low-power images of pathological sections. The editor again issued a conditional rejection, but kindly explained in the letter that the article would be accepted if the images were included. I immediately added the images and resubmitted the article, which was accepted in three days. Overall, it took a little over two months, but the efficiency of the journal was still very high. I hope this information is helpful to everyone(0) 讚! | 云来甲戌 |
作者: 极乐飞柏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-02-26 11:36:05 評論於 After revising it, two more reviewers were found for review, and now more revisions are needed. The status is conditional rejected. I don't know why another reviewer was found(0) 讚! | 极乐飞柏 |
作者: 罗汉铭晨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-02-22 10:36:27 評論於 This status means revision(0) 讚! | 罗汉铭晨 |
作者: 极乐飞柏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-01-20 18:18:55 評論於 Submitted for two months, one reviewer gave high praise without requiring any additional experiments; the other reviewer raised 10 questions, and the editor gave a "completed reject." Isn't this a bit exaggerated? I'm wondering if I should add some experiments to revise it. Sigh... it's almost Chinese New Year(0) 讚! | 极乐飞柏 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us